Three Scientists Share Nobel Prize for Hepatitis C Research

In HealthDay News
by Healthday

Nobel Committee described their work as ‘a landmark achievement in our battle against viral infections’

MONDAY, Oct. 5, 2020 (HealthDay News) — Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.

Hepatitis C causes 400,000 deaths worldwide each year, The Washington Post reported.

The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of Washington University in St. Louis; and British-born virologist Michael Houghton.

The researchers’ work was described by the Nobel Committee as “a landmark achievement in our battle against viral infections,” The Post reported.

The Washington Post Article

Copyright © 2020 HealthDay. All rights reserved.